Defending Valeant Pharmaceuticals, Top Investor Says Drugmaker's Lust For Profit Went Too Far |
| October 30, 2015 | October 2015 Bond Updates |
|
In defending Valeant Pharmaceuticals, top investor Ruane, Cunniff says the specialty drug company's decision to test the bounds of the law to maximize profits may have backfired. |
| View more at: http://www.forbes.com/sites/antoinegara/2015/10/29/valeant-ruane-cunniff-profits-ethics-legal-illegal-philidor-rx/ |
| Related News |
|